Next-generation sequencing studies had reported that a rare coding variant p.V232M in PLD3 was associated with Alzheimer’s disease (AD) and a two-fold increased AD risk in European cohorts. To test whether coding region variants of PLD3 were associated with AD in a large Han Chinese cohort, we performed sequencing to analyze all exons of PLD3, and demonstrated that rare variants p.I163M and c.1020-8G>A conferred considerable risk of late-onset AD (LOAD) in our cohort. Meanwhile, the previously reported p.V232M variant was identified in our AD group. These findings indicate that rare variants of PLD3 may play an important role in LOAD in northern Han Chinese.
van der LeeSJ, HolstegeH, WongTH, JakobsdottirJ, BisJC, ChourakiV, van RooijJG, GroveML, SmithAV, AminN, ChoiSH, BeiserAS, GarciaME, vanIWF, PijnenburgYA, LouwersheimerE, BrouwerRW, van den HoutMC, OoleE, EirkisdottirG, LevyD, RotterJI, EmilssonV, O’DonnellCJ, AspelundT, UitterlindenAG, LaunerLJ, HofmanA, BoerwinkleE, PsatyBM, DeStefanoAL, ScheltensP, SeshadriS, van SwietenJC, GudnasonV, van der FlierWM, IkramMA, van DuijnCM. (2015) PLD3 variants in population studies. Nature520, 2–3.
3.
SchulteEC, KurzA, AlexopoulosP, HampelH, PetersA, GiegerC, RujescuD, Diehl-SchmidJ, WinkelmannJ. (2015) Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease. Hum Genome Var2, 14028.
CacaceR, Van den BosscheT, EngelborghsS, GeertsN, LaureysA, DillenL, GraffC, ThonbergH, ChiangHH, PastorP, Ortega-CuberoS, PastorMA, Diehl-SchmidJ, AlexopoulosP, BenussiL, GhidoniR, BinettiG, NacmiasB, SorbiS, Sanchez-ValleR, LladoA, GelpiE, AlmeidaMR, SantanaI, TsolakiM, KoutroumaniM, ClarimonJ, LleoA, ForteaJ, de MendoncaA, MartinsM, BorroniB, PadovaniA, MatejR, RohanZ, VandenbulckeM, VandenbergheR, De DeynPP, CrasP, van der ZeeJ, SleegersK, Van BroeckhovenC. (2015) Rare variants in PLD3 do not affect risk for early-onset Alzheimer disease in a European Consortium Cohort. Hum Mutat36, 1226–1235.
8.
ZhangDF, FanY, WangD, BiR, ZhangC, FangY, YaoYG. (2016) PLD3 in Alzheimer’s Disease: A modest effect as revealed by updated association and expression analyses. Mol Neurobiol53, 4034–4045.
9.
JiaoB, LiuX, TangB, HouL, ZhouL, ZhangF, ZhouY, GuoJ, YanX, ShenL. (2014) Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer’s disease from mainland China.2422 e2429-2422 e. Neurobiol Aging35, 2411.
10.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM. (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
11.
JiangT, TanL, ChenQ, TanMS, ZhouJS, ZhuXC, LuH, WangHF, ZhangYD, YuJT. (2016) A rare coding variant in TREM2 increases risk for Alzheimer’s disease in Han Chinese.217 e. Neurobiol Aging42, 211–213.
12.
AdzhubeiIA, SchmidtS, PeshkinL, RamenskyVE, GerasimovaA, BorkP, KondrashovAS, SunyaevSR. (2010) A method and server for predicting damaging missense mutations. Nat Methods7, 248–249.
13.
KumarP, HenikoffS, NgPC. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc4, 1073–1081.
14.
XuM, ZhangDF, LuoR, WuY, ZhouH, KongLL, BiR, YaoYG. (2018) A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer’s disease. Alzheimers Dement14, 215–229.
15.
SatohJ, KinoY, YamamotoY, KawanaN, IshidaT, SaitoY, ArimaK. (2014) PLD3 is accumulated on neuritic plaques in Alzheimer’s disease brains. Alzheimers Res Ther6, 70.
WangC, WangHF, TanMS, LiuY, JiangT, ZhangDQ, TanL, YuJT. (2016) Impact of common variations in PLD3 on neuroimaging phenotypes in non-demented elders. Mol Neurobiol53, 4343–4351.
18.
WangC, TanL, WangHF, YuWJ, LiuY, JiangT, TanMS, HaoXK, ZhangDQ, YuJT. (2015) Common variants in PLD3 and correlation to amyloid-related phenotypes in Alzheimer’s disease. J Alzheimers Dis46, 491–495.
